Transcriptome of normal lung distinguishes mouse lines with different susceptibility to inflammation and to lung tumorigenesis

Cancer Letters

Volumn 294, Issue 2, 2010, Pages 187-194

  Franco, Marcelo De ^a   Colombo, Francesca ^b   Galvan, Antonella ^b   Cecco, Loris De ^b   Spada, Elena ^c   Milani, Silvano ^c   Ibanez, Olga M ^a   Dragani, Tommaso A ^b  

^a INSTITUTO BUTANTAN   (Brazil)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c Istituto di Statistica Medica e Biometria   (Italy)

Author keywords

Animal models; Inflammatory response; Microarray; MRNA profile

Indexed keywords

TRANSCRIPTOME; URETHAN;

ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL INFILTRATION; CELL LINE; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE TRANSENDOTHELIAL MIGRATION; LUNG PARENCHYMA; LUNG TUMORIGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIGHT JUNCTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICE; PNEUMONIA; URETHANE;

ANIMALIA; MUS;

EID: 77953478263     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.01.038     Document Type: Article

References (26)

1. Biozzi G., Ribeiro O.G., Saran A., et al. Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse. Carcinogenesis 1998, 19:337-346.
2. Maria D.A., Manenti G., Galbiati F., et al. Pulmonary adenoma susceptibility 1 (Pas1) locus affects inflammatory response. Oncogene 2003, 22:426-432.
3. Fernando R.C., Nair J., Barbin A., Miller J.A., Bartsch H. Detection of 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine by immunoaffinity/32P-postlabelling in liver and lung DNA of mice treated with ethyl carbamate (urethane) or its metabolites. Carcinogenesis 1996, 17:1711-1718.
4. Hoffler U., El Masri H.A., Ghanayem B.I. Cytochrome P450 2E1 (CYP2E1) is the principal enzyme responsible for urethane metabolism: comparative studies using CYP2E1-null and wild-type mice. J. Pharmacol. Exp. Ther. 2003, 305:557-564.
5. Gariboldi M., Spinola M., Milani S., Pignatiello C., Kadota K., Bono H., Hayashizaki Y., Dragani T.A., Okazaki Y. Gene expression profile of normal lungs predicts genetic predisposition to lung cancer in mice. Carcinogenesis 2003, 24:1819-1826.
6. Riggs P.K., Angel J.M., Abel E.L., DiGiovanni J. Differential gene expression in epidermis of mice sensitive and resistant to phorbol ester skin tumor promotion. Mol. Carcinogen. 2005, 44:122-136.
7. Fujiwara K., Ochiai M., Ubagai T., Ohki M., Ohta T., Nagao M., Sugimura T., Nakagama H. Differential gene expression profiles in colon epithelium of two rat strains with distinct susceptibility to colon carcinogenesis after exposure to PhIP in combination with dietary high fat. Cancer Sci. 2003, 94:672-678.
8. Falvella F.S., Pascale R.M., Gariboldi M., Manenti G., De Miglio M.R., Simile M.M., Dragani T.A., Feo F. Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats. Carcinogenesis 2002, 23:1933-1936.
9. Wright G.W., Simon R.M. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003, 19:2448-2455.
10. Carmona-Saez P., Chagoyen M., Tirado F., Carazo J.M., Pascual-Montano A. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol. 2007, 8:R3.
11. Schnoor M., Parkos C.A. Disassembly of endothelial and epithelial junctions during leukocyte transmigration. Front. Biosci. 2008, 13:6638-6652.
12. Vestweber D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol. Rev. 2007, 218:178-196.
13. Suzuki K., Kumanogoh A., Kikutani H. Semaphorins and their receptors in immune cell interactions. Nat. Immunol. 2008, 9:17-23.
14. Kruger R.P., Aurandt J., Guan K.L. Semaphorins command cells to move. Nat. Rev. Mol. Cell Biol. 2005, 6:789-800.
15. Holmes S., Downs A.M., Fosberry A., et al. Sema7A is a potent monocyte stimulator. Scand. J. Immunol. 2002, 56:270-275.
16. Rettig L., McNeill L., Sarner N., Guillaume P., Luescher I., Tolaini M., Kioussis D., Zamoyska R. An essential role for the stalk region of CD8 beta in the coreceptor function of CD8. J. Immunol. 2009, 182:121-129.
17. Inman B.A., Frigola X., Dong H., Kwon E.D. Costimulation, coinhibition and cancer. Curr. Cancer Drug Targets 2007, 7:15-30.
18. Noel P.J., Boise L.H., Thompson C.B. Regulation of T cell activation by CD28 and CTLA4. Adv. Exp. Med. Biol. 1996, 406:209-217.
19. Ji H., Houghton A.M., Mariani T.J., et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene 2006, 25:2105-2112.
20. To M.D., Perez-Losada J., Mao J.H., Hsu J., Jacks T., Balmain A. A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nat. Genet. 2006, 38:926-930.
21. Manenti G., Galbiati F., Giannì Barrera R., Pettinicchio A., Acevedo A., Dragani T.A. Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice. Oncogene 2004, 23:4495-4504.
22. Manenti G., Dragani T.A. Pas1 haplotype-dependent genetic predisposition to lung tumorigenesis in rodents: a meta-analysis. Carcinogenesis 2005, 26:875-882.
23. Lee S., Kang J., Cho M., et al. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches. Int. J. Oncol. 2009, 34:161-172.
24. Levine A.J., Hu W., Feng Z. The P53 pathway: what questions remain to be explored?. Cell Death Differ. 2006, 13:1027-1036.
25. Ghanayem B.I., Hoffler U. Investigation of xenobiotics metabolism, genotoxicity, and carcinogenicity using Cyp2e1(-/-) mice. Curr. Drug Metab. 2007, 8:728-749.
26. de Souza V.R., Cabrera W.K., Galvan A., Ribeiro O.G., De Franco M., Vorraro F., Starobinas N., Massa S., Dragani T.A., Ibanez O.M. Aryl hydrocarbon receptor polymorphism modulates DMBA-induced inflammation and carcinogenesis in phenotypically selected mice. Int. J. Cancer 2009, 124:1478-1482.